Transition of patients with interstitial lung disease from paediatric to adult care

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F21%3AN0000071" target="_blank" >RIV/00064190:_____/21:N0000071 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/21:10428365 RIV/00064203:_____/21:10428365 RIV/00216208:11130/21:10428365

Výsledek na webu

<a href="https://openres.ersjournals.com/content/erjor/7/2/00964-2020.full.pdf" target="_blank" >https://openres.ersjournals.com/content/erjor/7/2/00964-2020.full.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1183/23120541.00964-2020" target="_blank" >10.1183/23120541.00964-2020</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Transition of patients with interstitial lung disease from paediatric to adult care

Popis výsledku v původním jazyce

The European Cooperation in Science and Technology (COST) is a funding organisation for the creation of research networks, called COST Actions. COST Action 16125 was dedicated to European network for translational research in children's and adult interstitial lung disease. Working Group 5 of the COST Action CA16125 focussed on the problems of transition of children with interstitial lung diseases from paediatric to adult care. Results of this survey performed among members of the Working Group and some affiliated specialists showed highly variable and inadequate current system of transitions of these patients to adult care in most centres. In most centres there is no established and consistent procedure to guarantee appropriate transfer of information and prepare the patient for transition to a new specialist and a new team. Immediate action is therefore required. The Working Group has prepared a model procedure for the transition, based on protocols from several centres with established pathways, either for childhood interstitial lung disease or other chronic respiratory diseases.

Název v anglickém jazyce

Transition of patients with interstitial lung disease from paediatric to adult care

Popis výsledku anglicky

The European Cooperation in Science and Technology (COST) is a funding organisation for the creation of research networks, called COST Actions. COST Action 16125 was dedicated to European network for translational research in children's and adult interstitial lung disease. Working Group 5 of the COST Action CA16125 focussed on the problems of transition of children with interstitial lung diseases from paediatric to adult care. Results of this survey performed among members of the Working Group and some affiliated specialists showed highly variable and inadequate current system of transitions of these patients to adult care in most centres. In most centres there is no established and consistent procedure to guarantee appropriate transfer of information and prepare the patient for transition to a new specialist and a new team. Immediate action is therefore required. The Working Group has prepared a model procedure for the transition, based on protocols from several centres with established pathways, either for childhood interstitial lung disease or other chronic respiratory diseases.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30203 - Respiratory systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

ERJ open research

ISSN

2312-0541

e-ISSN

—

Svazek periodika

7

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

7

Strana od-do

Article Number 00964-2020

Kód UT WoS článku

000684169700053

EID výsledku v databázi Scopus

—